Preferred drug lists: Potential impact on healthcare economics

References

• AvornJBalancing the cost and value of medicationsPharmacoeconomics200220677212457426
   PubMed Web of Science ®Google Scholar
• [AHA] American Heart AssociationHeart and stroke statistical update2000Dallas, TXAmerican Heart Association
   Google Scholar
• BernasekCMendelsonDPadrezROregon’s Medicaid PDL: Will an evidence-based formulary with voluntary compliance set a precedent for Medicaid?2004
   Google Scholar
• Bussing-BurksMBenefits of newer prescription drugs exceed their costs2006 [online] Accessed 10 January 2006. URL: http://www.nber.org/digest/oct01/w8147.html
   Google Scholar
• CarrollNVHow effectively do managed care organizations influence prescribing and dispensing decisions?Am J Manag Care2002810415412500881
   PubMed Web of Science ®Google Scholar
• CauchiRFolkemerDRecent Medicaid prescription drug laws and strategies, 2001–20052006 [online] Accessed 1 September 2006. URL: http://www.ncsl.org/programs/health/medicaidrx.htm
   Google Scholar
• Center for Governmental Research, IncOn the road to Medicaid reform: a beginning2004 [online] Accessed 28 August 2006. URL: http://www.cgr.org/ICSG/Articles/?id=155
   Google Scholar
• CurtissFRManaging care via prior authorization (PA) programs?Manag Care Pharm20028296
   Google Scholar
• CurtissFRPrior authorization to manage drug utilization and costsManag Care Pharm2003995
   PubMedGoogle Scholar
• FinnertyPWStatus report on Virginia’s Medicaid Preferred Drug List (PDL) Program. Joint Commission on Health Care Behavioral Health Subcommittee2003107 [online] Accessed 29 August 2006. URL:http://www.dmas.virginia.gov/downloads/pdfs/pharmpdl_status_report_10-07-03.pdf
   Google Scholar
• Florida Medicaid Preferred Drug List2006720 [online] Accessed 1 September 2006. URL: http://www.fdhc.state.fl.us/Medicaid/Prescribed_Drug/pharm_thera/fmpdl.pdf
   Google Scholar
• GencarelliDMMedicaid prescription drug coverage: state efforts to control costsNational Health Policy Forum Issue Brief2003510790
   Google Scholar
• Georgia Medicaid/PeachCare Preferred Drug List2006125 [online] Accessed 1 September 2006. URL: http://dch.georgia.gov/vgn/images/portal/cit_1210/5/31/48919362GME_PDL_alpha_02-06.pdf
   Google Scholar
• GleasonPPGundersonBWGerickeKRAre incentive-based formularies inversely associated with drug utilization in managed care?Ann Pharmacother2005393394515644478
   PubMed Web of Science ®Google Scholar
• HamelMBEpsteinAMPrior-authorization programs for controlling drug spendingN Engl J Med20043512156815548775
   PubMed Web of Science ®Google Scholar
• Health Care Financing AdministrationOffice of the Actuary National Health Statistics Group2004
   Google Scholar
• HensleyPLNurnbergHGFormulary restriction of selective serotonin reuptake inhibitors for depressionPharmacoeconomics2001199738211735668
   PubMed Web of Science ®Google Scholar
• HuskampHADeverkaPAEpsteinAMThe effect of incentive-based formularies on prescription-drug utilization and spendingN Engl J Med200334922243214657430
   PubMed Web of Science ®Google Scholar
• JonesPKafonekSLauroraIComparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study)Am J Cardiol19988158279514454
   PubMed Web of Science ®Google Scholar
• Kaiser Commission on Medicaid and the Uninsured [online] Accessed 29 August 2006. URL: http://www.kff.org/medicaid/upload/Oregon-s-Medicaid-PDL-Will-an-Evidence-Based-Formulary-with-Voluntary-Compliance-Set-a-Precedent-for-Medicaid.pdf
   Google Scholar
• KardasPThe DIACOM study (effect of DosIng frequency of oral antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes)Diabetes Obes Metab20057722816219016
   PubMed Web of Science ®Google Scholar
• LichtenbergFRThe effect of access restrictions on the vintage of drugs used by Medicaid enrolleesAm J Manag Care200511SP71315700904
   PubMed Web of Science ®Google Scholar
• Louisiana Department of Health and HospitalsMedicaid Pharmaceutical and Therapeutics Committee Meeting Minutes200539 [online] Accessed 1 September 2006. URL: http://www.dhh.louisiana.gov/offices/publications/pubs-134/Approved%20BY%20P&TMin03%5B1%5D.09.05.pdf
   Google Scholar
• MaineCare Advisory CommitteeThe MaineCare Advisory Committee’s prior authorization subcommittee report and recommendations on prior authorization for prescription drugs in the Maine Care and Drugs for the Elderly Programs2005119
   Google Scholar
• MartinezGAssemblyman Peter M. Rivera questions Senate Medicaid report, calls recommendations a blue print for treating New York’s poor like guinea pigs2003 [online] Accessed 28 August 2006. URL: http://www.somoselfuturo.com/news_med2.htm
   Google Scholar
• MatteraMDA way to curb healthcare costs?Med Economics200438
   Google Scholar
• MurawskiMMAbdelgawadTExploration of the impact of preferred drug lists on hospital and physician visits and the costs to MedicaidAm J Manag Care200511SP354215700908
   PubMed Web of Science ®Google Scholar
• Preferred Drug List Program2006Juneau (AK)Health and Social Services, State of Alaska [online] Updated 8 August 2006. Accessed 1 September 2006. URL: http://www.hss.state.ak.us/dhcs/PDL/default.htm
   Google Scholar
• RudolphNVLubitzJCapitated payment approaches for Medicaid-financed long-term care servicesHealth Care Financ Rev199921516411481735
   PubMedGoogle Scholar
• SeayJDNAMI-NYS Action Agenda for 20042004 [online] Accessed 28 August 2006. URL: http://www.naminys.org/action_04.htm
   Google Scholar
• Silow-CarrollSAlteraTStretching state health care dollars: pooled and evidence-based pharmaceutical purchasingThe Commonwealth Fund2004102
   Google Scholar
• SmithGMHarperIMStowersADA cost analysis of switching calcium channel blockers: a one-year post-formulary decision reviewPharmacy Therapeutics20022733344
   Google Scholar
• SoumeraiSBBenefits and risks of increasing restrictions on access to costly drugs in MedicaidHealth Affairs2004231354615002636
   PubMed Web of Science ®Google Scholar
• State of Iowa Department of Human ServicesMedical Assistance Advisory Council Summary of Meeting200621 [online] Accessed 30 August 2006. URL: http://www.dhs.state.ia.us/dhs2005/ime/docs/2006FebMinutesNew.doc
   Google Scholar
• StrunkBCGinsburgPBGabelJRTracking health care costs: growth accelerates again in 2001Health Affairs2002Jul–DecSuppl Web ExclusivesW29931012703586
   PubMedGoogle Scholar
• StuartBSimoni-WastilaLChaunceyDAssessing the impact of coverage gaps in the Medicare Part D drug benefitHealth affairs2005 [exclusively on the internet] Accessed 28 August 2006. URL: http://www.allhealth.org/BriefingMaterials/HealthAffairs-AssessingTheImpact-46.pdf
   Google Scholar
• Texas Health and Human Services CommissionPreferred Drug List annual report: January 20052005 [online] Accessed 25 August 2006. URL: http://www.hhsc.state.tx.us/HCF/vdp/reports/010105_PDLAR.pdf
   Google Scholar
• VirabhakSShinogleJAPhysicians’ prescribing responses to a restricted formulary: the impact of Medicaid preferred drug lists in Illinois and LouisianaAm J Manag Care200511SP142015700905
   PubMed Web of Science ®Google Scholar
• WangRYPaulyMVSpillover effects of restrictive drug formularies: a case study of PacifiCare in CaliforniaAm J Manag Care20051124615697097
   PubMed Web of Science ®Google Scholar
• World Health OrganizationAdherence to long-term therapies: evidence for action2003 [online] Accessed 27 August 2006. URL: http://www.who.int/chronic_conditions/adherencereport/en/
   Google Scholar